Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 16968488)

1.

De novo malignancies following liver transplantation: a case-control study with long-term follow-up.

Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG.

Clin Transplant. 2006 Sep-Oct;20(5):617-23.

2.

Liver transplantation for critically ill patients with secondary sclerosing cholangitis: Outcome and complications.

Voigtländer T, Jaeckel E, Lehner F, Manns MP, Lankisch TO.

Liver Transpl. 2015 Jun 9. doi: 10.1002/lt.24192. [Epub ahead of print]

PMID:
26069199
3.

Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.

Jiménez-Romero C, Justo-Alonso I, Cambra-Molero F, Calvo-Pulido J, García-Sesma Á, Abradelo-Usera M, Caso-Maestro O, Manrique-Municio A.

World J Hepatol. 2015 May 8;7(7):942-53. doi: 10.4254/wjh.v7.i7.942. Review.

4.

Skin cancer in immunosuppressed transplant patients: Vigilance matters.

Unlu O, Roach EC, Okoh A, Olayan M, Yilmaz B, Uzunaslan D, Shatnawei A.

World J Hepatol. 2015 Apr 8;7(4):717-20. doi: 10.4254/wjh.v7.i4.717.

5.

De novo malignancy after liver transplantation: a single-center experience of 14 cases.

Gao PJ, Gao J, Li Z, Hu ZP, Zhu JY.

Ann Surg Treat Res. 2015 Apr;88(4):222-8. doi: 10.4174/astr.2015.88.4.222. Epub 2015 Mar 26.

6.

De novo formation of brain tumors in pediatric population following therapeutic cranial irradiation.

Bilginer B, Türk CC, Narin F, Hazer B, Hanalioglu S, Oguz KK, Soylemezoglu F, Akalan N.

Childs Nerv Syst. 2015 Jun;31(6):893-9. doi: 10.1007/s00381-015-2689-3. Epub 2015 Apr 2.

PMID:
25831997
7.

De novo Crohn's disease following orthotopic liver transplantation: a case report and literature review.

Naito T, Shiga H, Endo K, Kuroha M, Kakuta Y, Kinouchi Y, Shimosegawa T.

Intern Med. 2015;54(2):199-204. doi: 10.2169/internalmedicine.54.3156. Epub 2015 Jan 15.

8.

Characteristics of vertebral osteomyelitis after liver transplantation.

Buzelé R, Zarrouk V, Francoz C, Durand F, Fantin B.

Clin Microbiol Infect. 2015 Jun;21(6):573-7. doi: 10.1016/j.cmi.2015.01.018. Epub 2015 Jan 28.

PMID:
25726040
9.

[De novo malignant tumors following liver transplantation. A single-center experience in Argentina].

Antinucci F, Anders M, Orozco F, Mella J, Cobos M, McCormack L, Mastai R.

Medicina (B Aires). 2015;75(1):18-22. Spanish.

10.

A symptomatic de novo pheochromocytoma 23 years after liver transplantation: a case report and review of the literature.

Montenovo MI, Jalikis FG, Hoch B, Bakthavatsalam R.

Case Rep Transplant. 2014;2014:934385. doi: 10.1155/2014/934385. Epub 2014 Dec 14.

11.

Post-transplant malignancy in liver transplantation: a single center experience.

Hsiao CY, Lee PH, Ho CM, Wu YM, Ho MC, Hu RH.

Medicine (Baltimore). 2014 Dec;93(28):e310. doi: 10.1097/MD.0000000000000310. Erratum in: Medicine (Baltimore). 2015 Jan;94(1):1.

PMID:
25526480
12.

Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantation.

Coordes A, Albers AE, Lenarz M, Seehofer D, Puhl G, Pascher A, Neuhaus R, Neuhaus P, Pratschke J, Andreou A.

Head Neck. 2014 Dec 18. doi: 10.1002/hed.23943. [Epub ahead of print]

PMID:
25521431
13.

Management of de novo malignancies after liver transplantation.

Pillai AA.

Transplant Rev (Orlando). 2015 Jan;29(1):38-41. doi: 10.1016/j.trre.2014.11.002. Epub 2014 Nov 18.

PMID:
25510578
14.

Malignancy after renal transplantation: a single-center experience.

Vrotniakaite K, Jaceviciute R, Rudminiene I, Laucyte-Cibulskiene A, Rainiene T, Jankevicius F, Zelvys A, Miglinas M.

Ann Transplant. 2014 Sep 15;19:456-63. doi: 10.12659/AOT.890706.

15.

Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease.

Thimonier E, Guillaud O, Walter T, Decullier E, Vallin M, Boillot O, Dumortier J.

Clin Transplant. 2014 Dec;28(12):1339-48. doi: 10.1111/ctr.12430. Epub 2014 Sep 25.

PMID:
25081431
16.

The incidence and risk factors of de novo skin cancer in the liver transplant recipients.

Modaresi Esfeh J, Hanouneh IA, Dalal D, Tabba A, Lopez R, Pagadala M, Eghtesad B, Zein NN.

Int J Organ Transplant Med. 2012;3(4):157-63.

17.

De novo malignancy after liver transplant.

Sanaei AK, Aliakbarian M, Kazemi K, Nikeghbalian S, Shamsaeefar A, Mehdi SH, Bahreini A, Dehghani SM, Geramizadeh B, Malekhosseini SA.

Exp Clin Transplant. 2015 Apr;13(2):163-6. doi: 10.6002/ect.2013.0135. Epub 2014 May 19.

PMID:
24844266
18.

Posttransplant malignancies in liver transplant recipients.

Akdur A, Kırnap M, Yıldırım S, Altundağ Ö, Moray G, Haberal M.

Exp Clin Transplant. 2014 Mar;12 Suppl 1:162-5.

PMID:
24635818
19.

De novo cancers following liver transplantation: a single center experience in China.

Yu S, Gao F, Yu J, Yan S, Wu J, Zhang M, Wang W, Zheng S.

PLoS One. 2014 Jan 24;9(1):e85651. doi: 10.1371/journal.pone.0085651. eCollection 2014.

20.

Liver transplantation in children using organ donation after circulatory death: a case-control outcomes analysis of a 20-year experience in a single center.

Hong JC, Venick R, Yersiz H, Kositamongkol P, Kaldas FM, Petrowsky H, Farmer DG, Agopian V, McDiarmid SV, Hiatt JR, Busuttil RW.

JAMA Surg. 2014 Jan;149(1):77-82. doi: 10.1001/jamasurg.2013.3195.

PMID:
24257966
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk